A number of firms have modified their ratings and price targets on shares of Opko Health (NYSE: OPK) recently: 7/1/2016 – Opko Health was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish […]
